Edition:
United Kingdom

Laurus Labs Ltd (LAUL.NS)

LAUL.NS on National Stock Exchange of India

336.15INR
9:59am GMT
Change (% chg)

Rs2.65 (+0.79%)
Prev Close
Rs333.50
Open
Rs336.80
Day's High
Rs337.90
Day's Low
Rs330.35
Volume
5,782
Avg. Vol
38,632
52-wk High
Rs548.00
52-wk Low
Rs321.35

Latest Key Developments (Source: Significant Developments)

India's Laurus Labs Dec Qtr Net Profit After Tax Falls
Thursday, 31 Jan 2019 

Jan 31 (Reuters) - Laurus Labs Ltd ::DEC QUARTER NET PROFIT AFTER TAX 178.2 MILLION RUPEES VERSUS PROFIT 348.7 MILLION RUPEES YEAR AGO.DEC QUARTER REVENUE FROM OPERATIONS 529.5 MILLION RUPEES VERSUS 478.9 MILLION RUPEES YEAR AGO.  Full Article

CASI Pharmaceuticals Acquires HBV ANDA From Laurus Labs Ltd
Tuesday, 23 Oct 2018 

Oct 23 (Reuters) - Laurus Labs Ltd ::CASI PHARMACEUTICALS ACQUIRES HBV ANDA FROM LAURUS LABS LIMITED.CASI PHARMACEUTICALS INC - CASI WILL MAKE CERTAIN UPFRONT AND MILESTONE PAYMENTS IN DIFFERENT PHASES.  Full Article

India's Laurus Labs June-Qtr Consol Net PAT Falls
Friday, 3 Aug 2018 

Aug 3 (Reuters) - Laurus Labs Ltd ::JUNE QUARTER CONSOL NET PROFIT AFTER TAX 165.6 MILLION RUPEES VERSUS PROFIT 389.1 MILLION RUPEES YEAR AGO.JUNE QUARTER CONSOL REVENUE FROM OPERATIONS 5.39 BILLION RUPEES VERSUS 4.91 BILLION RUPEES YEAR AGO.  Full Article

Laurus labs gets EIR from US FDA for Visakhapatnam units
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Laurus Labs Ltd :Gets EIR from US FDA for unit 1, 3, at Parawada, Visakhapatnam, for inspection conducted in August 2017​.  Full Article

India's Laurus Labs Sept-qtr consol profit rises
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Laurus Labs Ltd ::Sept quarter consol net profit 487.6 million rupees versus 482.8 million rupees year ago.Sept quarter consol revenue from operations 5.39 billion rupees versus 5.25 billion rupees year ago.  Full Article